Synthesis and evaluation of 2'-substituted cyclobutyl nucleosides and nucleotides as potential anti-HIV agents. 2007

Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
Department of Chemistry, Emory University, Atlanta, GA 30322, USA.

A series of 2'-substituted cyclobutyl nucleoside analogs were efficiently prepared by constructing the core cyclobutyl ring using different [2+2] cycloaddition approaches. The triphosphate derivative of a cyclobutyl nucleoside was also synthesized and evaluated against wild-type and mutant HIV reverse transcriptases (RT). Whereas the nucleoside analogs were inactive against HIV-1 in culture, the nucleotide showed good activity not only against wild-type and recombinant HIV RT (IC(50)=4.7, 6.9 microM), but also against the M184I and M184V mutants (IC(50)=6.1, 6.9 microM) in cell-free assays.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003503 Cyclobutanes Four carbon cycloparaffin cyclobutane (the structural formula (CH2)4) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D017354 Point Mutation A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair. Mutation, Point,Mutations, Point,Point Mutations
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
September 1970, Angewandte Chemie (International ed. in English),
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
January 1997, Rapid communications in mass spectrometry : RCM,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
June 1990, Journal of medicinal chemistry,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
May 1996, Farmaco (Societa chimica italiana : 1989),
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
December 1993, Journal of medicinal chemistry,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
November 2011, Bioorganic & medicinal chemistry letters,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
June 2019, Bioorganic & medicinal chemistry,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
October 2018, Bioorganic chemistry,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
July 2008, Archives of pharmacal research,
Yongfeng Li, and Shuli Mao, and Michael W Hager, and Kimberlynne D Becnel, and Raymond F Schinazi, and Dennis C Liotta
November 2013, European journal of medicinal chemistry,
Copied contents to your clipboard!